{"id":"fc731f32-a962-540f-85d9-8aa9209f96a1","stable_key":"05a3cf47-e660-5ab3-8c32-5eba9847cf0a:thc-antagonist-rescues-memory","predicate":"prevents","statement":"The CB1 antagonist SR141716A attenuated the memory impairment produced by THC or by anandamide.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"50e620cd-4c42-5a66-ae0f-863c39fb3b54","mechanism_event_label":"Blocking the receptor protects the memory, whichever agonist caused the problem.","subject":{"id":"f4a1a50c-5e9d-5f48-98e9-d9c808c7b73a","slug":"sr141716a","display_name":"SR141716A / rimonabant, a CB1 receptor antagonist","entity_type_key":"drug"},"object":{"id":"5f4cf6d2-fb62-592c-b069-c30cd8e87830","slug":"spatial-memory","display_name":"Spatial memory performance","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"50e620cd-4c42-5a66-ae0f-863c39fb3b54","stable_key":"05a3cf47-e660-5ab3-8c32-5eba9847cf0a:thc-antagonist-rescues-memory-event","event_type":"biochemical_relationship","label":"Blocking the receptor protects the memory, whichever agonist caused the problem.","description":"The CB1 antagonist SR141716A attenuated the memory impairment produced by THC or by anandamide.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"daf9c6ee-5fd9-529c-8dfb-f26606ae40e3","slug":"anandamide","display_name":"Anandamide / arachidonylethanolamide","entity_type_key":"small_molecule"},"role":"compared_agonist","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"5a9e5b75-e6aa-5684-ad62-8a8d60148c84","slug":"tetrahydrocannabinol","display_name":"Delta-9-tetrahydrocannabinol / THC","entity_type_key":"drug"},"role":"blocked_agonist","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"f4a1a50c-5e9d-5f48-98e9-d9c808c7b73a","slug":"sr141716a","display_name":"SR141716A / rimonabant, a CB1 receptor antagonist","entity_type_key":"drug"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"5f4cf6d2-fb62-592c-b069-c30cd8e87830","slug":"spatial-memory","display_name":"Spatial memory performance","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/thc-research/9862397.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"59e00778f9e8b2a2aba64063224de431ef098aaffcf26dca95fd9ddb36981a1f\", \"start_char\": 0, \"end_char\": 1576, \"text_sha256\": \"59e00778f9e8b2a2aba64063224de431ef098aaffcf26dca95fd9ddb36981a1f\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Memory impairment by THC or anandamide with SR141716A pretreatment","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"THC or anandamide with a CB1 antagonist","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Shows the antagonist rescues the impairment for both the drug and the natural ligand.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"THC research collection; topical membership is not evidence of a direct clinical effect, and THC is recorded separately from the endocannabinoids it imitates.","comparator":null,"unit":null,"notes":"","entity":{"slug":"tetrahydrocannabinol","display_name":"Delta-9-tetrahydrocannabinol / THC","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Rat","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Blocking the receptor protects the memory, whichever agonist caused the problem.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[thc-p9862397] The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide. (1998). https://pubmed.ncbi.nlm.nih.gov/9862397/ DOI: 10.1007/s002130050733","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Behaviour","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"machinery_impairment","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"18a070a6-4be9-5adb-90e3-288fb27992bd","evidence_kind":"source_excerpt","locator":"Lines 452-463","start_line":452,"end_line":463,"excerpt":"### thc-antagonist-rescues-memory\nThe CB1 antagonist SR141716A attenuated the memory impairment produced by THC or by anandamide.\nCondition category: machinery_impairment\nnutrient_topic: THC research collection; topical membership is not evidence of a direct clinical effect, and THC is recorded separately from the endocannabinoids it imitates.\nplain_language: Blocking the receptor protects the memory, whichever agonist caused the problem.\norganism: Rat\ntissue_or_cell_type: Behaviour\nexperimental_model: Memory impairment by THC or anandamide with SR141716A pretreatment\nlimitations: Shows the antagonist rescues the impairment for both the drug and the natural ligand.\nexposure: THC or anandamide with a CB1 antagonist\nevidence_span: {\"source_cache\": \"artifacts/thc-research/9862397.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"59e00778f9e8b2a2aba64063224de431ef098aaffcf26dca95fd9ddb36981a1f\", \"start_char\": 0, \"end_char\": 1576, \"text_sha256\": \"59e00778f9e8b2a2aba64063224de431ef098aaffcf26dca95fd9ddb36981a1f\"}\n[thc-p9862397] The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide. (1998). https://pubmed.ncbi.nlm.nih.gov/9862397/ DOI: 10.1007/s002130050733","model_system":"Memory impairment by THC or anandamide with SR141716A pretreatment","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [thc-p9862397] The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide. (1998). https://pubmed.ncbi.nlm.nih.gov/9862397/ DOI: 10.1007/s002130050733","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"b4367320-9724-507a-bead-6932fa0a78cb","stable_key":"import-05a3cf47-e660-5ab3-8c32-5eba9847cf0a","title":"THC: the cannabinoid receptors, the endocannabinoid system it occupies, what the drug does, and the dietary fat it is built from (2026-09-21)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"60abc81737d18b7a50b01ca487e38291774ee15d9777651aa2d3eac8670ac3b2","revision_id":"2cba3552-af89-580d-b20a-8cfb1b14f9e7","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}